Ebola Vaccine Trial Begins In Sierra Leone

New York Times: Sierra Leone: Ebola Trial Begins
“Researchers began vaccinating volunteers in Sierra Leone with an experimental Ebola vaccine in a study officially begun on Monday. The trial, the third to begin in the West African countries hardest hit by Ebola, is sponsored by the Centers for Disease Control and Prevention, Sierra Leone’s Health Ministry, and the University of Sierra Leone’s College of Medicine and Allied Health Sciences…” (Fink, 4/13).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.